CANY
SGRY icon

Caxton Associates (New York)’s Surgery Partners SGRY Stock Holding History

Caxton Associates (New York)’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,573
Closed -$238K – 585
2021
Q2 		$238K Buy
+3,573
New +$194K 0.03% 378

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Caxton Associates (New York)'s SGRY Position: Q3 2021 in Review

Caxton Associates (New York) sold out of Surgery Partners (SGRY) in Q3 2021, closing a stake of 3,573 shares — an estimated $238K sold.

Caxton Associates (New York) first reported a position in SGRY in Q2 2021 and held it in 1 quarter. The position peaked at $238K in Q2 2021. 135 funds tracked by Wall St. Rank hold SGRY as of Q3 2021.

  • Caxton Associates (New York) reported no remaining Surgery Partners position as of Q3 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,573 Surgery Partners shares in Q3 2021, an estimated $238K.
  • Caxton Associates (New York) first reported a position in Surgery Partners in Q2 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s Surgery Partners position peaked at $238K in Q2 2021.
  • 135 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2021.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.